The increase in ERK1/2 activation upon rOSM stimulation of LIF-05-treated hepatoma cells (Fig. 3C, lane 10) indicated that the OSMR offers higher affinity binding sites for the activation of this MAPK pathway compared to the LIFR. Here, LIF is linked to hepatocellular carcinoma.